PERJETA conc perf 420 mg/14 ml flac 14 ml
7680625100014
CH-62510
L01FD02
07.16.1.
Reimbursement limitations:
PERJETA.01
Cancer du sein métastatique
PERJETA est remboursé en association avec le trastuzumab et le docétaxel …
1 / 3
google
Details
- Product number
- 6251001
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- pertuzumabum 420 mg, histidinum, acidum aceticum glaciale, saccharum, polysorbatum 20, aqua ad iniectabile, q.s. ad solutionem pro 14 ml.
Articles (1)
Perjeta 420 mg, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
420.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2530.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2015
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 62510
- Drug name
- Perjeta, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOPA
- ATC Code
- L01FD02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/08/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PERJETA conc perf 420 mg/14 ml flac 14 ml
- Description (DE)
- PERJETA Inf Konz 420 mg/14 ml Durchstf 14 ml
- Market launch
- 13/08/2012
- Narcotic (BTM)
- No